| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/19/2000 | EP1019090A1 Polymeric derivatives of camptothecins |
| 07/19/2000 | EP1019087A1 Ganglioside immunostimulating complexes and uses thereof |
| 07/19/2000 | EP1019086A1 Altered dna synthesome components as biomarkers for malignancy |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019081A2 Apolipoprotein e/growth factor complexes and methods of use |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019068A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/19/2000 | EP1019060A1 Androgen synthesis inhibitors |
| 07/19/2000 | EP1019059A1 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 07/19/2000 | EP1019057A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP1019037A1 Medicament containing delta-aminolevulinic acid |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1018877A1 Low molecular weight cell, bone marrow and immune stimulants |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |
| 07/19/2000 | EP0666845B1 Method for purifying beta-carotene |
| 07/19/2000 | EP0641355B1 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/19/2000 | CN1260796A Alkaloid halide salts of swainsonine and methods of use |
| 07/19/2000 | CN1260789A Heterocyclic compounds, method for preparing and medicine compositions containing same |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260725A Conjugate composing folic acid antagonist and carrier |
| 07/19/2000 | CN1260724A Nanoscale particles having iron oxide-containing core enveloped by at least two shells |
| 07/19/2000 | CN1260395A Human gene pRb-BP131 reacted with anti-cancer gene coded product pRB |
| 07/19/2000 | CN1260188A Dual-effect health-care powder |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/19/2000 | CN1054601C Fluoride like vitamine D3, its preparation method and use, and medicinal composition containing same |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CN1054541C Chinese medicine for treating mastosis |
| 07/19/2000 | CN1054510C Stable solution of rebeccamycin analog and preparation thereof |
| 07/19/2000 | CN1054509C Synergistic interplay of lymphokines and dsRNAs |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090941 Pharmaceutically active benzoquinazoline compounds |
| 07/18/2000 | US6090932 Method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090843 Benzothiophenes compounds which have useful pharmaceutical activity |
| 07/18/2000 | US6090840 Peptidyl compounds having MMP and TNF inhibitory activity |
| 07/18/2000 | US6090838 Methods and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090796 Anticancer, antitumor agent; viricide |
| 07/18/2000 | US6090789 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090583 Expression system in compatible host cell of a polynucleotide which produces a metalloprotease; diagnosis and treatment of asthma, disorders of leukotriene metabolism; anticarcinogenic agents; antiinflammatory/antidiabetic/antiarthritic agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090407 Administering anticancer drug to respiratory system |
| 07/18/2000 | US6090385 Method of treating cancer |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | US6090378 Cells which are allogeneic or xenogeneic for mammal, comprise a gene encoding interleukin-2, and a retrovirus which infects dividing cells of mammal and comprises a gene encoding thymidine kinase; antitumor agent |
| 07/18/2000 | US6090366 Process for the preparation of an organ specific antibodies labeled with technetium-99m |
| 07/18/2000 | CA2162689C Immunotoxins comprising gelonin and an antibody |
| 07/18/2000 | CA2113656C Isolation and structure of spongistatin 1 |
| 07/18/2000 | CA2111527C Phosphonooxymethyl ethers of taxane derivatives |
| 07/18/2000 | CA2017315C Interleukin i inhibitor |
| 07/18/2000 | CA2004332C Inhibition of cell adhesion |
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
| 07/13/2000 | WO2000040742A1 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/13/2000 | WO2000040734A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040714A2 Therapeutic phosphodiesterase inhibitors |
| 07/13/2000 | WO2000040701A2 Non-myeloablative tolerogenic treatment |
| 07/13/2000 | WO2000040699A2 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | WO2000040693A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040608A1 Proteins from rana pipiens and their use in the treatment of tumors |
| 07/13/2000 | WO2000040605A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 07/13/2000 | WO2000040600A1 Selective inhibitors of mmp-12 |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040595A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| 07/13/2000 | WO2000040592A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | WO2000040578A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040576A2 Thiopyran compounds as inhibitors of mmp |
| 07/13/2000 | WO2000040573A1 Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 07/13/2000 | WO2000040552A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040529A1 Colchinol derivatives as vascular damaging agents |
| 07/13/2000 | WO2000040275A2 The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
| 07/13/2000 | WO2000040271A2 P450 / acetaminophen gdept for cancer treatment |
| 07/13/2000 | WO2000040265A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | WO2000040264A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/13/2000 | WO2000040263A1 Production and use of a composition containing ivig for treating diseases that are characterized by elevated extracellular fasl titers |
| 07/13/2000 | WO2000040262A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 07/13/2000 | WO2000040260A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/13/2000 | WO2000040259A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | WO2000040257A1 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 07/13/2000 | WO2000040251A1 Use of adenosine agonists in cancer therapy |
| 07/13/2000 | WO2000040243A1 Novel compounds |
| 07/13/2000 | WO2000040238A1 Pharmaceutical formulations of taxanes |
| 07/13/2000 | WO2000040229A2 Synergistic tumorcidal response induced by histamine |
| 07/13/2000 | WO2000040228A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 07/13/2000 | WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | WO2000040088A1 Amide derivatives for antiangiogenic and/or antitumorigenic use |
| 07/13/2000 | WO2000027363B1 Aerosols comprising nanoparticle drugs |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000021986A3 Matrix-remodeling genes |
| 07/13/2000 | WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 07/13/2000 | WO2000020445A3 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/13/2000 | WO2000019976A3 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/13/2000 | WO2000018351A3 Aglyco products and methods of use |